Female athletes, long neglected by sports medicine research, lack information about how biology can impact their health and performance.May 19, 2023Check out STAT+Sponsored By Molly Ferguson for STAT After decades of neglecting women athletes, sport and exercise medicine is finally catching up Female athletes, long neglected by sports medicine research, lack information about how biology can impact their health and performance. By Amanda Loudin STAT+ | Novo Nordisk pauses ads for weight loss drug Wegovy as it struggles to meet demand "To avoid stimulating further demand for this medicine, we're pausing some key Wegovy promotional efforts," Novo Nordisk said. By Elaine Chen Gene therapy death not caused by CRISPR, investigators confirm The death of a Duchenne patient had raised concerns about the promise of custom-built gene therapies. By Jason Mast Alex Hogan/STAT STAT+ | Pear Therapeutics sold for parts at $6 million auction Click Therapeutics, Welt Corp, Harvest Bio, and Nox each acquired bits of Pear Therapeutics for $6 million. By Mario Aguilar STAT+ | FDA approves first treatment for skin condition that causes persistent wounds, a redosable gene therapy The gene therapy, known as Vyjuvek and made by Krystal Biotech, will soon be available for patients with dystrophic epidermolysis bullosa. By Andrew Joseph Opinion: Chelsea Clinton: How to eliminate viral hepatitis by 2030 Despite important efforts, eliminating hepatitis B and C by 2030 will be impossible if donor investments don't increase. By Chelsea Clinton and Finn Jarle Rode Adobe Opinion: How I helped Pfizer think through the ethics of Viagra 25 years ago Pfizer executives were terrified that marketing Viagra might lead to all manner of sex-related controversy. So they called me for a consult. By Arthur L. Caplan STAT+ | FDA official offers insights into whether gene therapy makers could use common manufacturing process FDA provides insights into its thinking about a groundbreaking approach to making gene therapies that could help commercialize the products. By John Wilkerson More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments